Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts

Thomas K. Karikari(University of Pittsburgh), Kaj Blennow(Sahlgrenska University Hospital)

The Lancet Neurology

April 22, 2020

10.1016/s1474-4422(20)30071-5

Cited by 1,331

Related Papers

Pittsburgh plasma p‐tau217: Classification accuracies for autosomal dominant and sporadic Alzheimer's disease in the community

|Alzheimer s & Dementia|2025|7

Pittsburgh plasma p-tau217: classification accuracies for autosomal dominant and sporadic Alzheimer’s disease in the community

|medRxiv|2025|1